Literature DB >> 23240165

Laboratory diagnosis of Streptococcus pneumoniae infections: past and future.

R Bandettini1, G Melioli.   

Abstract

Streptococcus pneumoniae is one of the most important causative agent of pneumonia, meningitis, bacteremia, sinusitis and otitis media. The gold standard diagnostic method is still culture even if bacteriological diagnosis is making progress in molecular biology and in proteomics areas.

Entities:  

Mesh：

Year:  2012        PMID： 23240165

Source DB:  PubMed          Journal:  J Prev Med Hyg        ISSN： 1121-2233


  5 in total

1.  The BinaxNOW pneumococcal antigen test: An adjunct for diagnosis of pneumococcal bacteraemia.

Authors:  Hafsah D Tootla; Colleen Bamford; Chad M Centner; Clinton Moodley
Journal:  S Afr J Infect Dis       Date:  2021-04-15

2.  Antibacterial effects of Traditional Chinese Medicine monomers against Streptococcus pneumoniae via inhibiting pneumococcal histidine kinase (VicK).

Authors:  Shuai Zhang; Jianmin Wang; Wenchun Xu; Yusi Liu; Wei Wang; Kaifeng Wu; Zhe Wang; Xuemei Zhang
Journal:  Front Microbiol       Date:  2015-05-20       Impact factor: 5.640

3.  The Relevance of a Novel Quantitative Assay to Detect up to 40 Major Streptococcus pneumoniae Serotypes Directly in Clinical Nasopharyngeal and Blood Specimens.

Authors:  Melina Messaoudi; Milen Milenkov; Werner C Albrich; Mark P G van der Linden; Thomas Bénet; Monidarin Chou; Mariam Sylla; Patricia Barreto Costa; Nathalie Richard; Keith P Klugman; Hubert P Endtz; Gláucia Paranhos-Baccalà; Jean-Noël Telles
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

4.  Characterization of highly conserved G-quadruplex motifs as potential drug targets in Streptococcus pneumoniae.

Authors:  Subodh Kumar Mishra; Neha Jain; Uma Shankar; Arpita Tawani; Tarun Kumar Sharma; Amit Kumar
Journal:  Sci Rep       Date:  2019-02-11       Impact factor: 4.379

5.  Distribution of 13-Valent pneumococcal conjugate vaccine serotype streptococcus pneumoniae in adults 50 Years and Older presenting with community-acquired pneumonia in Israel.

Authors:  Gili Regev-Yochay; Michal Chowers; Bibiana Chazan; Elisa Gonzalez; Sharon Gray; Zhou Zhang; Michael Pride
Journal:  Hum Vaccin Immunother       Date:  2018-09-06       Impact factor: 3.452
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.